Mallinckrodt Announces Extracorporeal Photopheresis Research Collaboration Agreement With Transimmune AG - PRNewswire
Mallinckrodt Announces Extracorporeal Photopheresis Research Collaboration Agreement With Transimmune AG PRNewswire
BEDMINSTER, N.J., Feb. 25, 2019 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE:MNK), a leading global specialty pharmaceutical company, today ...
Comments
Post a Comment